TI-2024-38071 Aliases CVE-2024-57783 GHSA-xq2f-f4gq-58p8

Cross-site scripting in alexpinel Dot

LOW 37CWE-79Published 2025-06-02 · Updated 2025-06-02

Key facts

Attack vector: Local
Privileges required: None
User interaction: None
Attack complexity: High
Impact type: Cross-site scripting
Confidentiality · integrity · availability: High · High · High
Fix status: No fix listed

Attack profile from CVSS 3.1 · CNA. Fix status from CNA. Impact type from CWE-79.

Summary

The desktop application in Dot through 0.9.3 allows XSS and resultant command execution because user input and LLM output are appended to the DOM with innerHTML (in render.js), and because the Electron window can access Node.js APIs.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV

EPSS 0.00236 14th percentileScored 2026-11-07

Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation: None
Automatable: No
Technical impact: Total

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

Vendor	Product	Affected versions	Fixed in	Status	Source
alexpinel	Dot	up to 0.9.3	—	No fix listed	CNA

Dot Vendoralexpinel Affected up to 0.9.3 Fixed in — No fix listed CNA

Remediation

No fixed version listed by the sources yet.

Timeline

2026-10-02 Threatist record created from CVE-2024-57783
2026-10-03 Alias added: GHSA-xq2f-f4gq-58p8

References

Other 3

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences